(March 31, 2025) – TheNewswire - Femto Technologies Inc. (Nasdaq: FMTO) (“Femto” or the “Company”), a FemTech pioneer and the creator of Sensera, a feminine wellness product, has released its financial results for the year ended December 31, 2024. Full versions of Femto’s audited consolidated financial statements and management discussion and analysis for the period, can be found on www.sedarplus.ca.

 

2024 Financial and Business Highlights:

 

• Revenue decreased 7% to $998,839 for the year ended December 31, 2024, from $1,076,861 for the same period in 2023. 

• Gross Profit decreased to 15% for the year ended December 31, 2024, from 37% for the same period in 2023. 

• Net loss increased 157% to $47,590,257 for the year ended December 31, 2024 from a net loss of $18,495,121 for the same period in 2023. 

• Working capital increased to $4,121,747 for December 31, 2024, from $2,441,703 for December 31,2023. 

• Total assets decreased to $30,241,067 for December 31, 2024, from $36,801,368 for December 31,2023. 

• Loss per share decreased 93% to $101.31 for the year ended December 31, 2024 from $1,550.4 for the same period in 2023. 

• Total shares outstanding as of December 31, 2024, were 655,369. 

• On February 28, 2025, the Company announced it has closed a private placement of approximately $17 million.  

• On January 6, 2025, the Company announced that it has been honored by the CES Innovation Awards® 2025  in the AI category for the Sensera device.  

• On October 30, 2024, the Company received the first shipment of the Sensera devices from the factory in China. 

  

Summary of Quarterly Comparison of Revenue, Gross Profit and Net Loss

 

	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Revenue	$182,306	$101,619	$405,946	$308,968	$205,121	$202,058	$251,047	$420,635
Gross Profit (loss)	$65,221	$(91,777)	$111,308	$65,950	$(56,711)	$72,085	$66,239	$316,943
Net Profit (loss)	$(11,631,845)*	$(5,418,470)**	$77,375	$(30,617,317)***	$(15,167,579)****	$(1,439,785)	$(1,147,324)	$(740,433)

 

*Includes change in fair value of derivative warrants in the amount of $6,978,939 and impairment expenses of $2,599,169.

**Includes impairments of intangible assets in the amount of $5,601,167.

***Includes change in fair value of derivative warrants liabilities in the amount of $28,977,934.

****Includes impairments of intangible assets and asset under construction in the amount of $13,142,481.

 

ABOUT SENSERA

Sensera is a feminine wellness device on a mission to bridge the gap between feminine pleasure and wellness, providing a holistic self-care experience that adapts to a woman’s changing needs. Sensera utilizes Femto’s proprietary Smart Release System (SRS) technology, including machine learning and AI, to enhance feminine wellness. Sensera is a CES Innovation Awards® 2025 Honorary in the AI category.

For more information on Sensera, please visit www.senserawellness.com and follow us on Instagram, Facebook, and YouTube. 

 

ABOUT FEMTO TECHNOLOGIES, INC.

Femto Technologies Inc. (Nasdaq: FMTO), previously known as BYND Cannasoft Enterprises Inc., is a public Femtech company, pioneering a transformative change in the sphere of female wellness. Its proprietary Smart Release System (SRS technology) is embedded in Sensera, which has been named CES Innovation Awards® 2025 honoree in the AI category. Femto’s SRS technology is driving its R&D activities and product manufacturing for a variety of Femtech products.

The devices described in this news release are concept devices that are in the first stage of development and will be subject to testing, experiments and regulatory approvals and therefore there is no certainty that they will eventually be marketed.

For more information, please visit www.femtocorp.com and on SEDAR+: www.sedarplus.ca

MEDIA CONTACT

For product demonstration and media

Samantha Breen

Opportunity PR (for Sensera)

samantha@opportunitypr.com

+1 949.290.2834

COMPANY CONTACT

Gabi Kabazo

Chief Financial Officer

Tel: (604) 833-6820

e‐mail: ir@femtocorp.com

Cautionary Note Regarding Forward-Looking Statements

This news release includes certain statements that may be deemed “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended and under Canadian securities laws. When used in this news release, the words “may”, “would”, “could”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions are intended to identify forward‐looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements.

Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company’s actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. Such statements reflect the Company's current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause actual results to differ materially from the statements made, including future financial performance,  unanticipated regulatory requests and delays, final patents approval, timing of the Sensera pre-order and those factors discussed in filings made by the company with the Canadian securities regulatory authorities, including (without limitation) in the company's management's discussion and analysis for the year ended December 31, 2024 and annual information form dated March 31, 2025, which are available under the company's profile at www.sedarplus.ca, and in the Company’s Annual Report on Form 20-F for the year then ended that was filed with the U.S. Securities and Exchange Commission on March 31, 2025. Should one or more of these factors occur, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forward‐looking statements, except as required by law. Any such forward-looking statements represent management's estimates as of the date of this news release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Shareholders are cautioned not to put undue reliance on such forward‐looking statements.